Markets.com Logo

PROGEN

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.6353$
  • Previous Close
    0.6411$
  • 52 Week Change
    26.96$
  • Day Range
    -0.01$
  • 52 Week High/Low
    0.5$ - 27.4625$
  • Dividend Per Share
    --
  • Market cap
    22 792 K$
  • EPS
    -80
  • Beta
    0.2
  • Volume
    --

About

PROGEN.ST represents Progenics Biopharma Inc. shares traded on the Nasdaq Stockholm stock exchange. It's a biotech company focused on developing innovative medicines and diagnostics for oncology, with a particular emphasis on targeted therapeutics and molecular imaging. The "ST" at the end of the ticker symbol signifies that it is listed on the Nasdaq Stockholm exchange, allowing investors in Sweden and other European markets to trade shares of the company. Investors should conduct thorough research into Progenics Biopharma's financial performance, pipeline development, and market conditions before making any investment decisions.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Company Performance: Progenics Therapeutics operational and financial performance directly influences its stock. Positive clinical trial results, successful drug approvals, and strong revenue growth typically lead to stock price increases.

Market Sentiment: Overall investor sentiment towards the biotechnology sector and pharmaceutical industry affects PROGEN.ST. Optimism about industry growth prospects can drive up stock prices, while pessimism can depress them.

Regulatory Events: Regulatory decisions by health agencies, such as FDA, regarding Progenics' drugs significantly impact stock value. Approvals boost prices, while rejections or delays can cause declines.

Competition: The competitive landscape within the pharmaceutical market influences investor perception. Introduction of competing drugs or therapies can negatively affect PROGEN.ST if they pose a threat to Progenics' market share.

Macroeconomic Factors: Broader economic conditions, including interest rates, inflation, and economic growth, impact stock prices. Economic downturns can reduce investor risk appetite, leading to sell-offs in more volatile stocks like PROGEN.ST.

News and Events: Company-specific news, such as management changes, partnerships, or acquisitions, can cause fluctuations in stock price. Positive news typically boosts prices, while negative news can depress them.

Analyst Ratings: Recommendations from financial analysts influence investor decisions. Positive ratings and price targets can encourage buying, while negative ratings can lead to selling pressure.

Clinical Trial Outcomes: The outcomes of clinical trials for Progenics' drug candidates are major price catalysts. Successful trial results that demonstrate efficacy and safety often lead to significant stock price appreciation.

Patent Protection: The strength and duration of patent protection for Progenics' products are crucial for maintaining market exclusivity and profitability. Loss of patent protection or challenges to patents can negatively affect stock value.

Investor Expectations: The market's expectations for Progenics' future performance play a significant role. If the company fails to meet expectations, even with positive results, the stock price may decline.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--